Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Peter Keen
Individual Investor

Peter Keen

Overview

Edit Overview Section
Number of Portfolio Companies 2
Number of Exits 
Unlock for free
  • Investor Type 
    obfuscation
  • Investor Stage 
    obfuscation
  • Number of Exits 
    obfuscation

Personal Investments

Edit Personal Investments Section
Number of Investments 4
Peter Keen has made 4 investments. Their latest investment was Seed Round - SupaPass on
obfuscation
, when SupaPass raised
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
SupaPass Logo
SupaPass
—
Seed Round - SupaPass Logo
Seed Round - SupaPass
obfuscation
obfuscation
Small Pharma Logo
Small Pharma
No
Seed Round - Small Pharma Logo
Seed Round - Small Pharma
obfuscation
obfuscation
SupaPass Logo
SupaPass
Yes
Seed Round - SupaPass Logo
Seed Round - SupaPass
obfuscation
obfuscation
SupaPass Logo
SupaPass
—
Seed Round - SupaPass Logo
Seed Round - SupaPass
obfuscation

Exits

Edit Exits Section
Number of Exits 
Unlock for free
Peter Keen has
obfuscation
exit - Small Pharma. Peter Keen has
obfuscation
exits. Their most notable exits are Small Pharma.
  • Small Pharma Logo
    Small Pharma Small Pharma is dedicated to identifying these opportunities.

Jobs

Edit Jobs Section
Number of Current Jobs 1
Number of Past Jobs 6
Peter Keen is the Independent Investment Committee Member at British Patient Capital. Additionally, Peter Keen has had 6 past jobs including Director at Cambridge Innovation Capital.
Organization Name  
Title At Company  
Start Date  
End Date  
Cambridge Innovation Capital Logo
Cambridge Innovation Capital
Director—Feb 1, 2016
Horizon Discovery Logo
Horizon Discovery
Non - Executive Director—2013
Serentis Logo
Serentis
Team Member——
CelltechGroup.com Logo
CelltechGroup.com
Director, Finance / Co - Founder (Chiroscience Group plc)——
Molten Ventures Logo
Molten Ventures
Venture Partner——
Arakis Logo
Arakis
CFO——

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 1
Number of Past Board & Advisor Roles 1
Peter Keen is the Chairman at Exosect.
Organization Name  
Title At Company  
Start Date  
End Date  
Biotech Growth Logo
Biotech Growth
Non - Executive Director——

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 1
Funding Round•Mar 30, 2020
SupaPass raised
obfuscation
from Angel Academe and 4 other investors
Discover more funding rounds
News•Nov 16, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Funding Round•Apr 10, 2017
Small Pharma raised
obfuscation
from ACF Investors and 5 other investors
Discover more funding rounds
Funding Round•Dec 4, 2015
SupaPass raised
obfuscation
from Anglia Capital Group and 7 other investors
Discover more funding rounds
Funding Round•Nov 6, 2014
SupaPass raised
obfuscation
from Angels Den and 7 other investors
Discover more funding rounds
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|